DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/x3zcsf/russia) has announced the addition of the "Russia Pharmaceutical Industry" report to their offering.
The pharmaceutical industry in Russia has been witnessing strong growth over the last couple of years, with the alimentary/metabolism segment leading the market. The industry grew by 17.5% in 2009 and is expected to reach a value of $10.7 billion by the year 2014.
The Russian pharmaceutical market accounts for just 3.6% of the European pharmaceutical industry in terms of value and Sanofi-Aventis holds the major market share in the industry. Pharmstandard also has a major presence in the market.
Taiyou Research presents an analysis of the Russian Pharmaceutical Market in its research report Russia Pharmaceutical Industry.
The report covers the following:
- A complete analysis of the global pharmaceutical industry, including a market profile and outlook.
- Role of the TRIPS agreement in the pharmaceutical industry. The section covers the increasing cost of medicines worldwide and the role of product patents. The transfer of technical knowledge and the flexibility in the TRIPS agreements is also discussed.
- An in-depth analysis of the Russian pharmaceutical market, including market profile, market share of the leading companies, market value, segmentation of the market, followed by the outlook for the industry.
- An analysis of the competition in the industry is included.
Key Topics Covered:
1. Executive Summary
2. Profiling the Global Pharmaceutical Industry
3. Role of TRIPS in the Pharmaceutical Industry
4. Russian Pharmaceutical Market
5. Competitive Landscape
6. Major Players
7. Glossary
Companies Mentioned
- Pfizer Inc
- Novartis AG
- Sanofi-Aventis SA
- Menarini Group
- Pharmstandard
- Johnson & Johnson
For more information visit http://www.researchandmarkets.com/research/x3zcsf/russia